Mastering Pharmacovigilance Agreements

Explore the essential elements of a pharmacovigilance agreement, including introduction with party names and addresses, scope, definitions, responsibilities, audits, confidentiality, retention, and appendices.

Explore the five-stage life cycle of a pharmacovigilance agreement—from awareness to preparation and negotiation, implementation, maintenance and changes, and termination—outlining department responsibilities, templates, data flows, and how changes are performed.

Compare limited and detailed pharmacovigilance agreements, covering safety data collection and exchange, training and audits, and learn how third party agreements allocate roles among MA holders, distributors, and providers.

Explore safety data exchange agreements in pharmacovigilance, detailing responsibilities, regulatory compliance, and timelines. Learn how these contracts support audits and shared safety information among marketing authorisation holders and partners.

Draft a new pharmacovigilance agreement by staying current with regulations, tailoring it to the product and market, establishing clear communication channels, and ensuring data privacy, security, and lifecycle considerations.

Update pharmacovigilance agreements by reviewing changes in regulations, new safety data, product changes, market shifts, party changes, and emerging safety concerns to ensure ongoing safety management.

Outline a pharmacovigilance agreements amendment by identifying triggers such as new safety data, documenting description, reason, and date, obtaining regulatory approval, and implementing updates to all stakeholders.

Explore how a PVA addendum adds articles and other information to pharmacovigilance agreements, and learn when new regulations, new responsibilities, or additional important details necessitate it.

Identify the reason for termination and review the pharmacovigilance agreement; notify all parties, address outstanding issues, ensure regulatory compliance, and document the termination.

Review the draft pharmacovigilance agreement before finalization, address concerns, obtain signatures, distribute copies, implement the terms on the effective date, and monitor compliance while updating as needed.

Establish a monitoring procedure to assess pharmacovigilance agreement compliance, define a compliance matrix for reporting timelines, adverse events, data privacy, and finances, and conduct reviews with corrective actions and audits.

Complete Mastering pharmacovigilance agreements, retrieve your certificate, and share it on LinkedIn. Access downloadable slides and explore pharmacovigilance agreements, dea safety data exchange agreements, qppv roles, audits, and courses.